A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)
Solmaz Sahebjam(Johns Hopkins University), Sebastién J. Hotte(Juravinski Cancer Centre)
Cited by 76
Related Papers
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated <i>MGMT</i> promoter
|Neuro-Oncology|2022|508
Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer
|European Urology|2020|90
Identification of Hypermutation and Defective Mismatch Repair in ctDNA from Metastatic Prostate Cancer
|Clinical Cancer Research|2019|77